Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance

Fertility and Sterility

Volumn 95, Issue 1, 2011, Pages 310-313

  Caglar, Gamze S ^a   Oztas, Efser ^a   Karadag, Demet ^a   Pabuccu, Recai ^a   Demirtas, Selda ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

cardiovascular risk; insulin resistance; ischemia modified albumin; Ovary syndrome

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HOMOCYSTEINE; INSULIN; ISCHEMIA MODIFIED ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID STENOSIS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; ISCHEMIA; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; SERUM ALBUMIN; YOUNG ADULT;

EID: 78650420165     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.06.092     Document Type: Article

References (34)

1. E. Dahlgren, P.O. Janson, S. Johansson, L. Lapidus, and A. Odén Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women Acta Obstet Gynecol Scand 71 1992 599 604
2. R.S. Legro, A.R. Kunselman, and A. Dunaif Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome Am J Med 111 2001 607 613
3. A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. Vanvoorhis, and D.H. Jagasia Screening women with polycystic ovary syndrome for metabolic syndrome Obstet Gynecol 106 2005 131 137
4. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of risk for type 2 DM and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169
5. S. Sam, and A. Dunaif Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14 2003 365 370
6. T. Apridonidze, P.A. Essah, M.J. Iuorno, and J.E. Nestler Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 1929 1935
7. K.J. Mather, F. Kwan, and B. Corenblum Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity Fertil Steril 73 2000 150 156
8. G. Paradisi, H.O. Steinberg, A. Hempfling, J. Cronin, G. Hook, and M.K. Shepard Polycystic ovary syndrome is associated with endothelial dysfunction Circulation 103 2001 1410 1415
9. F. Orio Jr., S. Palomba, T. Cascella, B. de Simone, S. di Biase, and T. Russo Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 4588 4593
10. E.O. Talbott, D.S. Guzick, K. Sutton-Tyrrell, K.P. McHugh-Pemu, J.V. Zborowski, and K.E. Remsberg Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women Arterioscler Thromb Vasc Biol 20 2000 2414 2421
11. E. Carmina, F. Orio, S. Palomba, R.A. Longo, T. Cascella, and A. Colao Endothelial dysfunction in PCOS: role of obesity and adipose hormones Am J Med 119 2006 356.e1-6
12. E.O. Talbott, J.V. Zborowski, M.Y. Boudreaux, K.P. McHugh-Pemu, K. Sutton-Tyrrell, and D.S. Guzick The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 6061 6067
13. A. Dokras Cardiovascular disease risk factors in polycytic ovary syndrome Semin Rerod Med 26 2008 39 44
14. E. Corrado, M. Rizzo, G. Coppola, K. Fattouch, G. Novo, and I. Marturana An update on the role of markers of inflammation in atherosclerosis J Atheroscler Thromb 17 2010 1 11
15. S. Guven, S.C. Karahan, C. Bayram, U. Ucar, and M. Ozeren Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease Reprod Biomed Online 19 2009 493 500
16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 82 Suppl 3 2004 1193 1197
17. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, and G. Sullivan Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
19. P. Pignoli, E. Tremoli, A. Poli, P. Oreste, and R. Paoletti Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 74 1986 1399 1406
20. D.C. Gaze Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia Drug Metab Pharmacokinet 24 2009 333 341
21. F. Prefumo, D.C. Gaze, A.T. Papageorghiou, P.O. Collinson, and B. Thilaganathan First trimester maternal serum ishemia modified albumin: a marker of hypoxia-ischemia-driven early trophoblast development Hum Reprod 22 2007 2029 2032
22. M. Montagnana, G. Lippi, A. Volpe, G.L. Salvagno, D. Biasi, and P. Caramaschi Evaluation of cardiac laboratory markers in patients with systemic sclerosis Clin Biochem 39 2006 913 917
23. B.A. Maddux, W. See, J.C. Lawrance Jr., A.L. Goldfine, I.D. Goldfine, and J.L. Evans Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of a-lipoic acid Diabetes 50 2001 404 410
24. J.L. Evans, B.A. Maddux, and I.D. Goldfine The molecular basis for oxidative stress-induced insulin resistance Antioxid Redox Signal 7 2005 1040 1052
25. P. Libby, P.M. Ridker, and G.K. Hansson Inflammation in Atherosclerosis J Am Coll Cardiol 54 2009 2129 2138
26. A. Piwowar, M. Knapik-Kordecka, and M. Warwas Ischemia modified albumin level in type 2 diabetes mellitus - preliminary report Dis Markers 24 2008 311 317
27. M. Kaefer, S.J. Piva, J.A. De Carvalho, D.B. Da Silva, A.M. Becker, and A.C. Coelho Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus Clin Biochem 43 2010 450 454
28. L.M. Hulten, and M. Levin The role of hypoxia in atherosclerosis Curr Opin Lipidol 20 2009 409 414
29. C.C. Kelly, H. Lyall, J.R. Petrie, G.W. Gould, J.M. Connell, and N. Sattar Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2001 2453 2455
30. N. Boulman, Y. Levy, R. Leiba, S. Shachar, R. Linn, and O. Zinder Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease J Clin Endocrinol Metab 89 2004 2160 2165
31. W. Mak, and A. Dokras Polycystic ovary syndrome and the risk of cardiovascular disease and thrombosis Semin Thromb Hemost 35 2009 613 620
32. M. Möhlig, J. Spranger, M. Osterhoff, M. Ristow, A.F. Pfeiffer, and T. Schill The polycystic ovary syndrome per se is not associated with increased chronic inflammation Eur J Endocrinol 150 2004 525 532
33. I. Lemieux, A. Pascot, D. Prud'homme, N. Alméras, P. Bogaty, and A. Nadeau Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity Arterioscler Thromb Vasc Biol 21 2001 961 967
34. T. Pierpoint, P.M. McKeigue, A.J. Isaccs, S.H. Wild, and H.S. Jacobs Mortality of women with polycystic ovary syndrome at long-term follow-up J Clin Epidemiol 51 1998 581 586